Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline for Cognitive Deficits in Parkinson's Disease
NCT00696215Phase 4Unknown
- Sponsor
- Istanbul University
- Start
- Jun 2007
- Primary completion
- Jun 2008
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Parkinson's disease (PD) comparing Placebo with Rasagiline (2 arms). Primary endpoint: Total Cognitive Score at 3 months. Status: unknown.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00696215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00696215.